In an article published on August 17, 2019 in Healthcare Business Today, Chris Sloan and Bruce Doeg provide insight into disruptive healthcare and legal questions facing these initiatives.
"Disruption in any industry creates new and interesting regulatory problems, because, almost by definition, dramatic changes in technology and business models challenge existing laws in often unexpected ways," said Sloan and Doeg, adding that laws are difficult and slow to change, so there is an inevitable delay before the law catches up to the disruptive technology.
Disruptive healthcare initiatives face a number of legal questions including, are telemedicine providers permitted to treat patients in other starts or countries; is telemedicine covered by insurance; who are the business associates for HIPPA purposes; do applications using artificial intelligence constitute medical devices; and more.
"There are many other questions remaining to be answered… The potential for these and other disruptive technologies to transform U.S. healthcare is enormous," according to the authors. Interested parties can only wait and hope that regulators respond quickly and pragmatically to these changes.
For the full article, you may click here.